Effects of bone mineral density of gonadotropin releasing hormone analogs used in the treatment of central precocious puberty

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue 3, 2003, Pages 407-411

  Ünal, Özlem ^a,b   Berberoǧlu, Merih ^a   Evliyaoǧlu, Olcay ^a   Adiyaman, Pelin ^a   Aycan, Zehra ^a   Öcal, Gönül ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Bone mineral density; Central precocious puberty; Children; Gonadotropin releasing hormone analogs

Indexed keywords

GONADORELIN DERIVATIVE; LEUPRORELIN;

ARTICLE; BONE AGE; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; IDIOPATHIC DISEASE; LUMBAR VERTEBRA; OSTEOPENIA; OSTEOPOROSIS; PRECOCIOUS PUBERTY; PUBERTY; SCHOOL CHILD; STATISTICAL ANALYSIS; VERTEBRA;

EID: 0141995488     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2003.16.3.407     Document Type: Article

References (19)

1. Bachrach LK. Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls. J Pediatr Endocrinol Metab 2000; 13 (Suppl 2): 983-988.
2. Tatò L, Antoniazzi F, Zamboni G. Bone mass formation in childhood and risk of osteoporosis. Pediatr Med Chir 1996; 18: 373-375.
3. Antoniazzi F, Bertoldo F, Zamboni G, Valentini R, Sirpresi S, Cavallo L, Adami S, Tatò L. Bone mineral metabolism in girls with precocious puberty during gonadotropin releasing hormone agonist treatment. Eur J Endocrinol 1995; 133: 412-417.
4. Saggese G, Bertelloni S, Baroncelli GI, Battini R, Franchi G. Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr 1993; 152: 717-720.
5. Verotti A, Chiarelli F, Montanaro AF, Morgese G. Bone mineral content in girls with precocious puberty treated with gonodotroin releasing hormone analog. Gynecol Endocrinol 1995; 9: 277-281.
6. Antoniazzi F, Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Borelli P, Osio D, Mengarda F, De Luca F, Tatò L. End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000; 13: 773-780.
7. Bertelloni S, Baroncelli GI, Ferdeghini M, Menchini-Fabris F, Saggese G. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. Eur 3 Pediatr 2000; 159: 369-374.
8. Bertelloni S, Baroncelli GI, Sorentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonodotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998; 157: 363-367.
9. Heger S, Partsch CJ, Sippell WG. Long term outcome after depot gonadotropin releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999; 84: 4583-4590.
10. Neely EK, Bachrach LK, Hintz RL, Habiby RL, Slemenda CW, Feezle L, Pescovitz OH. Bone mineral density during treatment of central precocious puberty. J Pediatr 1995; 127: 819-822.
11. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 219-303.
12. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and wrist, 2nd Ed. Stanford, CA: Stanford University Press, 1959.
13. Lee PA. Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med 1994; 148: 369-376.
14. Rubin K, Schirduan V, Gendreau P, Sarfarazzi M, Mendola R, Dalsky G. Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty. J Pediatr 1993; 123: 863-870.
15. Boot AM, de Muinck Keizer-Schrama SMPF, Pols HA, Krenning EP, Drop SL. Bone mineral density and body composition before and during treatment with gonadotropin releasing hormone agonist in children with central precocious and early puberty. J Clin Endocrinol Metab 1998; 83: 370-373.
16. Saggese G, Perri G, Sorentino MC, Baroncelli GI, Bertelloni S. Effect of central precocious puberty and gonadotropin releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998; 157: 363-367.
17. Antoniazzi F, Bertoldo F, Lauriola S, Sirpresi S, Gasperi E, Zamboni G, Tatò L. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin releasing hormone agonist treatment. J Clin Endocrinol Metab 1999; 84: 1992-1996.
18. Rakover Y, Lu P, Briody JN, Tao C, Weiner E, Ederveen AG, Cowell CT, Ben-Shlomo L. Effects of delaying puberty on bone mineralization in female rats. Hum Reprod 2000; 15: 1457-1461.
19. Ruiz Echarri M, Ferrandez Longas A, Mayayo Dehesa E. Bone mass evolution in patients with precocious and advanced puberty treated with LHRH analogs. An Esp Pediatr 1999; 51: 499-504.